States regarding consumer protection actions involving wrongful marketing practices and failure to warn about possible health risks
FDA approval is being sought for this drug to be used for weight loss
J Clin Endocrinol Metab 89(6):25832589
We analyzed ratings from more than 1,100 physicians who evaluated Ozempic, Mounjaro, Wegovy, and Zepbound on Sermos platform, alongside survey feedback from over 300 active GLP-1 prescribersincluding PCPs, endocrinologists, cardiologists, gastroenterologists, and pulmonologists
To gain additional insights into participants' experiences with GLP-1 and their impact on nicotine cravings and withdrawal symptoms, an open-ended question was included in the survey: "Is there anything else you would like to share about your experience with GLP-1 and their impact on nicotine cravings and withdrawal symptoms?" Responses to this open-ended question were analyzed using thematic analysis